Informazioni su ADMA Biologics Inc - Common Stock Panoramica della società da Wikipedia

Wikidata ↗

ADMA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo

$9.38

Capitalizzazione di Mercato

$2.23B

P/E (TTM)

15.6

EPS (TTM)

$0.60

Ricavi (TTM)

$510M

Rendimento div.

—

ROE

33.6%

D/E Debito/Patrimonio

0.2

Intervallo 52 sett.

$7 – $20

ADMA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $510M

2023-12-31 → 2025-12-31

EPS $0.60

2023-12-31 → 2025-12-31

Flusso di cassa libero $28M

2023-12-31 → 2025-12-31

Margini 28.8%

2023-12-31 → 2025-12-31

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica

Tendenza 5 anni

ADMA

Mediana dei peer

P/E (TTM)

15.6

55.4

P/S (TTM)

4.4

7.7

P/B

4.7

7.1

EV / EBITDA

11.1

—

Price / FCF (Prezzo / FCF)

80.2

—

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica

Tendenza 5 anni

ADMA

Mediana dei peer

Gross Margin (Margine lordo)

57.4%

71.7%

Operating Margin (Margine Operativo)

37.5%

—

Net Profit Margin (Margine di Profitto Netto)

28.8%

-2.0%

ROA

26.4%

-32.7%

ROE

33.6%

-37.9%

ROIC

28.0%

—

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica

Tendenza 5 anni

ADMA

Mediana dei peer

Debt / Equity (Debito / Patrimonio Netto)

0.2

18.7

Current Ratio (Rapporto corrente)

6.7

7.4

Quick Ratio

3.5

—

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica

Tendenza 5 anni

ADMA

Mediana dei peer

Revenue YoY (Ricavi YoY)

19.6%

—

Revenue CAGR 3Y (CAGR Ricavi 3Y)

49.0%

—

Revenue CAGR 5Y (CAGR Ricavi 5Y)

64.6%

—

EPS YoY

-25.9%

—

Net Income YoY (Utile Netto YoY)

-25.7%

—

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica

Tendenza 5 anni

ADMA

Mediana dei peer

EPS (Diluted) (EPS (Diluito))

$0.60

—

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica

Tendenza 5 anni

ADMA

Mediana dei peer

ADMA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 11 analisti

Acquisto forte 2 18,2%
Compra 7 63,6%
Mantieni 2 18,2%
Vendi 0 0,0%
Vendita forte 0 0,0%

Target Price a 12 Mesi

5 analisti · 2026-08-17

Mediana $17.00

← Sotto tutti i target $9.38

Basso $12.00

Alto $21.00

Target mediano $17.00 +81,1%

Target medio $17.00 +81,1%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media

-0.01%

Periodo	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	$0.16	$0.18	-0.02%
31 Marzo 2026	$0.19	$0.20	-0.01%
31 Dicembre 2025	$0.20	$0.19	0.01%
30 Settembre 2025	$0.15	$0.15	-0.00%
30 Giugno 2025	$0.14	$0.14	-0.00%
31 Marzo 2025	$0.11	$0.16	-0.05%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
ADMA	$4.34B	30.4	19.6%	28.8%	33.6%	57.4%
VCEL	$1.82B	112.5	16.4%	6.0%	5.0%	74.4%
PVLA	$1.30B	-28.2	65.3%	-1610.6%	-110.1%	—
BHVN	$1.50B	-1.6	—	—	-310.8%	—
VRDN	$3.17B	-7.7	23359.9%	-483.6%	-55.4%	—
STOK	$1.87B	-264.5	404.5%	-3.7%	-2.0%	—
ZBIO	$1.98B	-4.3	100.0%	-3777.4%	-156.8%	—
AGIO	$1.59B	-3.8	48.0%	-764.0%	-32.2%	—
TSHA	$1.57B	-16.2	17.3%	-1115.3%	-44.0%	—
GENB	—	—	—	—	—	—

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 18

Dati annuali Conto Economico per ADMA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$510M	$426M	$258M	$154M	$81M	$42M	$29M	$17M	$23M	$11M	$7M	$6M
Cost of Revenue	$217M	$207M	$169M	$119M	$80M	$61M	$40M	$42M	$29M	$2M	$4M	$4M
Gross Profit	$293M	$220M	$89M	$35M	$1M	$-19M	·	$-25M	$-6M	$4M	$3M	$2M
R&D Expense	$5M	$2M	$3M	$4M	$4M	$6M	$2M	$4M	$6M	$8M	$7M	$10M
SG&A Expense	$92M	$74M	$59M	$52M	$43M	$35M	$26M	$23M	$19M	$8M	$7M	$5M
Operating Expenses	$101M	$81M	$67M	$75M	$60M	$46M	$71M	$77M	$62M	$28M	$23M	$22M
Operating Income	$191M	$139M	$22M	$-39M	$-58M	$-65M	$-41M	$-60M	$-39M	$-17M	$-16M	$-16M
Interest Expense	·	·	$25M	$19M	$13M	$12M	$9M	$6M	$3M	$2M	$2M	$1M
Interest Income	$2M	$2M	$2M	$45.0K	$35.0K	$288.1K	$800.8K	·	·	·	·	·
Other Non-op	$-212.0K	$-193.0K	$-287.0K	$-635.0K	$-252.0K	$-128.5K	$-227.3K	$-127.1K	$-10.1K	$4.5K	$-2M	$-1M
Pretax Income	$183M	$126M	$-28M	$-66M	·	·	·	·	·	$-20M	$-18M	$-17M
Income Tax	$36M	$-72M	$0	$0	$0	$0	$0	$0	$0	$0	$0	$-551.7K
Net Income	$147M	$198M	$-28M	$-66M	$-72M	$-76M	$-48M	$-66M	$-44M	$-20M	$-18M	$-17M
EPS (Basic)	$0.62	$0.85	$-0.13	$-0.33	$-0.51	$-0.88	·	·	·	·	·	·
EPS (Diluted)	$0.60	$0.81	$-0.13	$-0.33	$-0.51	$-0.88	·	·	·	·	·	·
Shares (Basic)	238,299,024	233,084,236	223,977,315	197,874,895	139,578,538	86,145,052	·	·	·	·	·	·
Shares (Diluted)	244,904,640	243,342,466	223,977,315	197,874,895	139,578,538	86,145,052	·	·	·	·	·	·
EBITDA	$199M	$147M	$29M	$-33M	$-54M	$-62M	$-39M	$-58M	$-38M	$-17M	$-15M	$-16M

Stato Patrimoniale 28

Dati annuali Stato Patrimoniale per ADMA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$88M	$103M	$51M	$87M	$51M	$56M	$27M	$27M	$43M	$10M	$10M	$17M
Short-term Investments	·	·	·	·	·	·	·	·	$0	$5M	$6M	$5M
Receivables	$158M	$50M	$27M	$16M	$29M	$13M	$3M	$1M	$4M	$1M	$924.5K	$384.0K
Inventory	$206M	$170M	$173M	$163M	$125M	$82M	$53M	$19M	$13M	$5M	$3M	$2M
Prepaid Expense	$7M	$8M	$5M	$5M	$4M	$3M	$3M	$2M	$1M	$313.9K	$111.0K	$143.6K
Current Assets	$467M	$331M	$257M	$270M	$209M	$154M	$86M	$45M	$62M	$22M	$21M	$24M
PP&E (Net)	$65M	$55M	$54M	$58M	$51M	$42M	$32M	$30M	$30M	$2M	$2M	$3M
PP&E (Gross)	$103M	$88M	$81M	$78M	$64M	$50M	$37M	$34M	$32M	$4M	$4M	$4M
Accum. Depreciation	$38M	$34M	$27M	$19M	$13M	$9M	$6M	$3M	$1M	$2M	$2M	$1M
Goodwill	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$0	·	·
Intangibles	$632.0K	$460.0K	$499.0K	$1M	$2M	$2M	$3M	$4M	$5M	$0	·	·
Total Assets	$624M	$489M	$329M	$348M	$276M	$208M	$127M	$89M	$108M	$24M	$24M	$27M
Accounts Payable	$23M	$20M	$16M	$13M	$12M	$11M	$9M	$6M	$6M	$3M	$2M	$2M
Accrued Liabilities	·	·	·	·	·	$8M	$4M	$4M	$3M	$2M	$2M	$2M
Short-term Debt	·	·	·	·	·	·	·	$0	$0	$6M	$0	·
Current Liabilities	$70M	$56M	$50M	$39M	$30M	$20M	$14M	$10M	$9M	$11M	$4M	$4M
Capital Leases	$7M	$9M	$10M	$11M	$7M	$4M	$1M	$119.1K	$0	$19.7K	$36.3K	$51.4K
Other Non-current Liabilities	$0	$360.0K	$419.0K	$350.0K	$397.4K	$54.9K	$106.6K	$260.7K	$106.0K	$117.8K	$1M	$132.5K
Total Liabilities	$147M	$140M	$194M	$196M	$135M	$119M	$101M	$69M	$68M	$28M	$23M	$21M
Long-term Debt	$72M	$72M	·	·	·	·	$0	$3M	$3M	$2M	·	·
Total Debt	$72M	·	·	·	·	·	·	$0	$0	$6M	·	·
Common Stock	$24.0K	$24.0K	$23.0K	$22.0K	$19.6K	$10.5K	$5.9K	$4.6K	$3.7K	$1.3K	$1.1K	$929
Paid-in Capital	$671M	$658M	$641M	$630M	$553M	$429M	$291M	$236M	$191M	$102M	$88M	$75M
Retained Earnings	$-162M	$-309M	$-506M	$-478M	$-412M	$-340M	$-265M	$-216M	$-151M	$-107M	$-87M	$-69M
Treasury Stock	$32M	$0	·	·	·	·	·	·	·	·	·	·
Stockholders' Equity	$477M	$349M	$135M	$152M	$141M	$88M	$26M	$20M	$40M	$-4M	$821.0K	$6M
Liabilities + Equity	$624M	$489M	$329M	$348M	$276M	$208M	$127M	$89M	$108M	$24M	$24M	$27M
Shares Outstanding	237,874,496	236,620,545	226,063,032	221,816,930	195,813,817	104,902,888	59,318,355	46,353,068	36,725,499	12,886,741	10,713,087	9,291,823

Flusso di cassa 18

Dati annuali Flusso di cassa per ADMA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$8M	$8M	$8M	$6M	$5M	$3M	$2M	$3M	$2M	$400.0K	$469.8K	$247.9K
Stock-based Comp	$20M	$14M	$6M	$5M	$3M	$3M	$3M	$2M	$2M	$1M	$2M	$1M
Deferred Tax	$11M	$-84M	$0	$0	·	·	·	·	·	·	·	·
Amort. of Intangibles	$144.0K	$388.0K	$724.0K	$715.0K	$715.0K	$715.4K	$844.9K	$844.9K	$1M	$0	·	·
Other Non-cash	$-136M	$-16M	$23M	$-5M	$-49M	$-32M	$-33M	$-2M	$3M	$-473.5K	$370.7K	$611.9K
Operating Cash Flow	$50M	$119M	$9M	$-60M	$-112M	$-102M	$-76M	$-63M	$-37M	$-18M	$-15M	$-15M
CapEx	$23M	$8M	$5M	$14M	$14M	$13M	$4M	$2M	$3M	$73.4K	$26.1K	$2M
Investing Cash Flow	$-22M	$-9M	$-5M	$-14M	$-14M	$-13M	$-4M	$-2M	$15M	$904.6K	$-2M	$-4M
Debt Issued	·	·	·	·	·	$28M	$72M	$0	$30M	$4M	·	·
Net Debt Issued	·	·	·	·	·	$14M	$72M	$0	$30M	·	·	·
Stock Issued	·	$0	$0	$65M	$121M	$131M	$48M	$43M	$39M	$13M	$10M	$0
Stock Repurchased	$32M	$0	$0	·	·	·	·	·	·	·	·	·
Net Stock Activity	$-32M	$0	$0	$65M	$121M	$131M	$48M	$43M	$39M	$14M	$10M	$0
Financing Cash Flow	$-44M	$-58M	$-39M	$109M	$121M	$144M	$80M	$43M	$61M	$17M	$10M	$10M
Net Change in Cash	$-16M	$52M	$-35M	$35M	$-5M	$29M	$-2.7K	$-22M	$39M	$-526.1K	$-7M	$-9M
Taxes Paid	$20M	·	·	·	·	·	·	·	·	·	·	·
Free Cash Flow	$28M	$110M	$4M	$-73M	$-126M	$-115M	$-80M	$-65M	$-40M	$-18M	$-15M	$-17M
Levered FCF	·	·	·	·	·	·	·	·	·	$-21M	$-17M	$-18M

Redditività 8

Dati annuali Redditività per ADMA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Gross Margin	57.4%	51.5%	34.4%	22.9%	1.5%	·	·	-148.4%	-28.1%	40.3%	39.9%	36.7%
Operating Margin	37.5%	32.6%	8.4%	-25.6%	-72.1%	-153.8%	-141.1%	-354.9%	-172.7%	-162.6%	-216.1%	-270.8%
Net Margin	28.8%	46.4%	-10.9%	-42.8%	-88.5%	-179.4%	-164.5%	-387.1%	-192.3%	-183.1%	-250.4%	-284.2%
Pretax Margin	35.8%	29.5%	·	·	·	·	·	·	·	-183.1%	-250.4%	-293.6%
EBITDA Margin	39.1%	34.4%	11.3%	-21.4%	-66.2%	-146.2%	-133.0%	-339.6%	-166.1%	-158.1%	-209.6%	-266.6%
ROA	26.4%	45.0%	-8.3%	-20.3%	-27.8%	-38.1%	-47.0%	-67.3%	-66.5%	-82.3%	-70.8%	-56.8%
ROE	33.6%	68.1%	-19.7%	-52.2%	-58.7%	-94.9%	-155.0%	-230.8%	-243.9%	1073.4%	-526.2%	-153.5%
ROIC	28.0%	62.6%	·	·	·	·	·	·	·	-1047.9%	-1889.7%	-258.1%

Liquidità e Solvibilità 5

Dati annuali Liquidità e Solvibilità per ADMA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	6.7	6.0	5.2	6.9	6.9	7.7	6.1	4.6	6.7	1.9	5.0	5.7
Quick Ratio	3.5	2.8	1.6	2.6	2.6	3.5	2.2	2.5	5.0	1.5	4.2	5.3
Debt / Equity	0.2	·	·	·	·	·	·	0.0	0.0	-1.4	·	·
LT Debt / Equity	0.1	·	·	·	·	·	·	·	·	·	·	·
Interest Coverage	·	·	0.9	-2.0	-4.5	-5.4	-4.6	-10.9	-12.0	-7.7	-8.4	-12.5

Efficienza 3

Dati annuali Efficienza per ADMA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.9	1.0	0.8	0.5	0.3	0.2	0.3	0.2	0.3	0.4	0.3	0.2
Inventory Turnover	1.2	1.2	1.0	0.8	0.8	0.9	1.1	2.7	0.3	1.5	1.7	2.8
Receivables Turnover	4.9	11.0	12.0	7.0	3.9	5.1	12.1	6.4	9.3	11.0	11.0	13.6

Per Azione 5

Dati annuali Per Azione per ADMA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$2.01	$1.48	$0.60	$0.69	$0.72	$0.84	$0.44	$0.43	$1.10	$-0.35	$0.08	$0.65
Revenue / Share	$2.08	$1.75	$1.15	$0.78	$0.58	·	·	·	·	·	·	·
Cash Flow / Share	$0.21	$0.49	$0.04	$-0.30	$-0.81	·	·	·	·	·	·	·
Cash / Share	$0.37	$0.44	$0.23	$0.39	$0.26	$0.53	$0.45	$0.49	$1.17	$0.77	$0.97	$1.85
EPS (TTM)	$0.60	$0.81	$-0.13	$-0.33	$-0.51	$-0.88	·	·	·	·	·	·

Tassi di Crescita 5

Dati annuali Tassi di Crescita per ADMA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	19.6%	65.1%	67.6%	90.4%	91.7%	·	·	·	·	·	·	·
Revenue CAGR 3Y	49.0%	74.0%	82.9%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	64.6%	·	·	·	·	·	·	·	·	·	·	·
EPS YoY	-25.9%	·	·	·	·	·	·	·	·	·	·	·
Net Income YoY	-25.7%	·	·	·	·	·	·	·	·	·	·	·

Valutazione (TTM) 14

Dati annuali Valutazione (TTM) per ADMA
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$510M	$426M	$258M	$154M	$81M	$42M	$29M	$17M	$23M	$11M	$7M	$6M
Net Income TTM	$147M	$198M	$-28M	$-66M	$-72M	$-76M	$-48M	$-66M	$-44M	$-20M	$-18M	$-17M
Market Cap	$4.34B	$4.06B	$1.02B	$861M	$276M	$205M	$237M	$111M	$118M	$66M	$86M	$104M
Enterprise Value	$4.32B	·	·	·	·	·	·	$88M	$75M	$57M	·	·
P/E	30.4	21.2	-34.8	-11.8	-2.8	-2.2	·	·	·	·	·	·
P/S	8.5	9.5	4.0	5.6	3.4	4.8	8.1	6.5	5.2	6.2	12.0	17.5
P/B	9.1	11.6	7.6	5.7	2.0	2.3	9.1	5.6	2.9	-14.8	105.3	17.3
P / Tangible Book	9.2	11.8	7.8	5.8	2.0	2.5	·	·	·	·	·	·
P / Cash Flow	86.1	34.2	116.1	-14.5	-2.5	-2.0	-3.1	-1.8	-3.2	-3.6	-5.6	-7.1
P / FCF	156.0	36.7	253.6	-11.7	-2.2	-1.8	-3.0	-1.7	-3.0	-3.6	-5.6	-6.1
EV / EBITDA	21.7	·	·	·	·	·	·	-1.5	-2.0	-3.4	·	·
EV / FCF	155.4	·	·	·	·	·	·	-1.4	-1.9	-3.1	·	·
EV / Revenue	8.5	·	·	·	·	·	·	5.2	3.3	5.3	·	·
Earnings Yield	3.3%	4.7%	-2.9%	-8.5%	-36.2%	-45.1%	·	·	·	·	·	·

Conto Economico 18

Dati trimestrali Conto Economico per ADMA
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$124M	$114M	$139M	$134M	$122M	$115M	$118M	$120M	$107M	$82M	$74M	$67M	$60M	$57M	$50M	$41M
Cost of Revenue	$38M	$34M	$50M	$59M	$55M	$54M	$54M	$60M	$50M	$43M	$43M	$43M	$43M	$40M	$36M	$31M
Gross Profit	$86M	$81M	$89M	$76M	$67M	$61M	$63M	$60M	$57M	$39M	$31M	$25M	$17M	$17M	$14M	$10M
R&D Expense	$6M	$3M	$1M	$2M	$1M	$826.0K	$391.0K	$412.0K	$560.0K	$450.0K	$446.0K	$596.0K	$1M	$855.0K	$1M	$1M
SG&A Expense	$27M	$27M	$24M	$22M	$22M	$24M	$23M	$19M	$17M	$16M	$16M	$15M	$14M	$15M	$14M	$13M
Operating Expenses	$34M	$22M	$26M	$25M	$24M	$26M	$25M	$20M	$18M	$17M	$17M	$16M	$17M	$17M	$20M	$19M
Operating Income	$52M	$58M	$63M	$51M	$43M	$35M	$38M	$40M	$39M	$22M	$14M	$9M	$-473.0K	$-813.0K	$-6M	$-9M
Interest Expense	·	·	·	·	·	·	·	·	·	$4M	·	$6M	$6M	$6M	·	$6M
Interest Income	·	·	$487.0K	$376.0K	$400.0K	$608.0K	$598.0K	$666.0K	$449.0K	$384.0K	$614.0K	$423.0K	$414.0K	$166.0K	$2.4K	$7.2K
Other Non-op	$-22.0K	$-140.0K	$-19.0K	$-21.0K	$-108.0K	$-64.0K	$-86.0K	$-56.0K	$-16.0K	$-35.0K	$-102.0K	$-145.0K	$-13.0K	$-27.0K	$-439.1K	$-9.6K
Pretax Income	$50M	$57M	$62M	$48M	$40M	$33M	$35M	$37M	$36M	$18M	$-18M	$3M	$-6M	$-7M	·	·
Income Tax	$12M	$12M	$12M	$11M	$6M	$7M	$-77M	$840.0K	$4M	$595.0K	$0	$0	$0	$0	·	·
Net Income	$38M	$45M	$49M	$36M	$34M	$27M	$112M	$36M	$32M	$18M	$-18M	$3M	$-6M	$-7M	$-12M	$-15M
EPS (Basic)	$0.17	$0.19	$0.22	$0.15	$0.14	$0.11	$0.48	$0.15	$0.14	$0.08	$-0.08	$0.01	$-0.03	$-0.03	$-0.05	$-0.08
EPS (Diluted)	$0.16	$0.19	$0.20	$0.15	$0.14	$0.11	$0.45	$0.15	$0.13	$0.08	$-0.08	$0.01	$-0.03	$-0.03	$-0.05	$-0.08
Shares (Basic)	228,232,503	236,072,751	-479,570,145	238,602,978	241,490,715	237,775,476	-462,779,632	234,571,376	232,417,645	228,874,847	-445,904,808	225,276,980	222,683,393	221,921,750	-390,734,157	196,383,935
Shares (Diluted)	230,337,048	239,955,762	-493,044,433	244,664,263	248,608,460	244,676,350	-480,043,045	244,804,065	242,167,072	236,414,374	-454,389,090	233,761,262	222,683,393	221,921,750	-390,734,157	196,383,935
EBITDA	$54M	$60M	·	$53M	$45M	$37M	·	$42M	$41M	$24M	·	$11M	$1M	$1M	·	$-8M

Stato Patrimoniale 25

Dati trimestrali Stato Patrimoniale per ADMA
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$136M	$138M	$88M	$61M	$90M	$72M	$103M	$87M	$88M	$45M	·	$74M	$63M	$69M	·	$35M
Receivables	$138M	$136M	$158M	$138M	$110M	$99M	$50M	$50M	$30M	$50M	·	$31M	$37M	$27M	·	$21M
Inventory	$239M	$222M	$206M	$197M	$191M	$172M	$170M	$172M	$180M	$178M	·	$163M	$162M	$164M	·	$163M
Prepaid Expense	$15M	$15M	$7M	$7M	$8M	$9M	$8M	$10M	$6M	$4M	·	$5M	$5M	$4M	·	$5M
Current Assets	$528M	$511M	$467M	$403M	$400M	$352M	$331M	$318M	$304M	$276M	·	$274M	$266M	$264M	·	$224M
PP&E (Net)	$67M	$65M	$65M	$70M	$58M	$58M	$55M	$54M	$54M	$55M	·	$55M	$56M	$57M	·	$57M
PP&E (Gross)	$108M	$105M	$103M	·	$95M	$93M	$88M	$86M	$85M	$84M	·	$80M	$80M	$79M	·	$75M
Accum. Depreciation	$42M	$40M	$38M	·	$38M	$35M	$34M	$32M	$31M	$29M	·	$25M	$23M	$21M	·	$18M
Goodwill	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	·	$4M	$4M	$4M	·	$4M
Intangibles	$575.0K	$630.0K	$632.0K	$491.0K	$527.0K	$452.0K	$460.0K	$485.0K	$479.0K	$321.0K	·	$476.9K	$655.7K	$834.6K	·	$1M
Total Assets	$684M	$665M	$624M	$569M	$558M	$511M	$489M	$391M	$376M	$351M	$329M	$349M	$343M	$341M	$348M	$301M
Accounts Payable	$32M	$21M	$23M	$24M	$30M	$21M	$20M	$16M	$14M	$17M	·	$11M	$12M	$13M	·	$25M
Current Liabilities	$76M	$74M	$70M	$56M	$75M	$53M	$56M	$45M	$44M	$53M	·	$42M	$42M	$37M	·	$44M
Capital Leases	$6M	$6M	$7M	$9M	$9M	$8M	$9M	$9M	$9M	$9M	·	$10M	$10M	$10M	·	$11M
Other Non-current Liabilities	·	·	$0	$90.0K	$2.0K	$2.0K	$360.0K	$375.0K	$390.0K	$405.0K	·	$434.6K	$449.5K	$338.7K	·	$362.2K
Total Liabilities	$276M	$275M	$147M	$138M	$160M	$137M	$140M	$159M	$188M	$197M	·	$198M	$196M	$195M	·	$200M
Long-term Debt	$197M	$197M	$72M	$72M	·	·	$72M	·	·	·	·	·	·	·	·	·
Total Debt	$197M	$197M	·	$72M	·	·	·	·	·	·	·	·	·	·	·	·
Common Stock	$24.0K	$24.0K	$24.0K	$24.0K	$24.0K	$24.0K	$24.0K	$24.0K	$23.0K	$23.0K	·	$22.6K	$22.5K	$22.2K	·	$19.7K
Paid-in Capital	$675M	$650M	$671M	$665M	$661M	$655M	$658M	$652M	$645M	$642M	·	$640M	$638M	$630M	·	$566M
Retained Earnings	$-79M	$-116M	$-162M	$-211M	$-247M	$-282M	$-309M	$-420M	$-456M	$-488M	·	$-489M	$-491M	$-485M	·	$-466M
Treasury Stock	$188M	$143M	$32M	$23M	$15M	·	$0	·	·	·	·	·	·	·	·	·
Stockholders' Equity	$408M	$390M	$477M	$431M	$398M	$373M	$349M	$232M	$188M	$154M	$135M	$151M	$147M	$146M	$152M	$100M
Liabilities + Equity	$684M	$665M	$624M	$569M	$558M	$511M	$489M	$391M	$376M	$351M	·	$349M	$343M	$341M	·	$301M
Shares Outstanding	225,355,228	232,288,977	237,874,496	238,332,393	238,567,308	238,532,252	236,620,545	236,378,607	233,026,736	231,769,765	·	225,958,084	224,526,748	222,262,588	·	196,776,871

Flusso di cassa 15

Dati trimestrali Flusso di cassa per ADMA
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Stock-based Comp	$6M	$6M	$5M	$5M	$5M	$5M	$5M	$3M	$3M	$2M	$2M	$2M	$2M	$1M	$1M	$1M
Deferred Tax	$3.0K	$3M	$1M	$5M	$2M	$3M	$-84M	$0	$0	$0	·	·	·	·	·	·
Amort. of Intangibles	$55.0K	$55.0K	$49.0K	$38.0K	$32.0K	$25.0K	$25.0K	$28.0K	$142.0K	$193.0K	$187.0K	$179.0K	$179.0K	$179.0K	$178.5K	$178.8K
Other Non-cash	·	$2M	·	·	·	$-57M	·	·	·	$-24M	·	·	·	$-11M	·	·
Operating Cash Flow	$30M	$58M	$36M	$13M	$21M	$-20M	$50M	$25M	$46M	$-2M	$18M	$12M	$-6M	$-15M	$-7M	$-13M
CapEx	$2M	$3M	$1M	$14M	$2M	$5M	$3M	$1M	$2M	$2M	$1M	$756.8K	$872.4K	$2M	$4M	$3M
Investing Cash Flow	$-2M	$2M	$-276.0K	$-14M	$-3M	$-5M	$-3M	$-1M	$-2M	$-2M	$-1M	$-756.8K	$-872.4K	$-2M	$-4M	$-3M
Stock Issued	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$65M	$0
Stock Repurchased	$25M	$130M	$9M	$23M	$0	$0	$0	·	·	·	·	·	·	·	·	·
Net Stock Activity	·	$-130M	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$-29M	$-10M	$-9M	$-28M	$48.0K	$-7M	$-31M	$-25M	$-362.0K	$-1M	$-39M	$416.4K	$240.5K	$-650.0K	$63M	$-843.8K
Net Change in Cash	$-2M	$51M	$26M	$-29M	$19M	$-32M	$16M	$-2M	$43M	$-6M	$-23M	$12M	$-7M	$-17M	$52M	$-18M
Free Cash Flow	·	$56M	·	·	·	$-24M	·	·	·	$-5M	·	·	·	$-17M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-8M	·	·	·	·	·	·

Redditività 8

Dati trimestrali Redditività per ADMA
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	69.4%	70.5%	·	56.3%	55.1%	53.2%	·	49.8%	53.6%	47.8%	·	36.6%	27.8%	29.0%	·	23.5%
Operating Margin	42.2%	50.9%	·	38.0%	35.1%	30.4%	·	33.1%	36.6%	26.7%	·	12.9%	-0.79%	-1.4%	·	-22.7%
Net Margin	30.4%	39.6%	·	27.1%	28.1%	23.4%	·	30.0%	29.9%	21.8%	·	3.8%	-10.6%	-11.9%	·	-36.3%
Pretax Margin	40.4%	49.9%	·	35.4%	32.9%	29.1%	·	30.7%	33.5%	22.5%	·	·	·	·	·	·
EBITDA Margin	43.5%	52.5%	·	39.5%	36.7%	32.0%	·	34.7%	38.3%	29.0%	·	15.7%	2.4%	1.9%	·	-18.5%
ROA	6.1%	7.7%	·	7.6%	7.3%	6.2%	·	9.7%	8.9%	5.1%	·	0.79%	-2.0%	-2.1%	·	-5.5%
ROE	9.4%	11.9%	·	11.0%	11.7%	10.2%	·	18.7%	19.1%	11.9%	·	2.0%	-4.9%	-5.0%	·	-14.7%
ROIC	6.5%	7.9%	·	7.8%	9.2%	7.5%	·	16.7%	18.6%	13.7%	·	·	·	·	·	·

Liquidità e Solvibilità 5

Dati trimestrali Liquidità e Solvibilità per ADMA
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	7.0	7.0	·	7.1	5.3	6.6	·	7.1	6.9	5.2	·	6.5	6.3	7.2	·	5.0
Quick Ratio	3.6	3.7	·	3.5	2.7	3.2	·	3.0	2.7	1.8	·	2.5	2.4	2.6	·	1.3
Debt / Equity	0.5	0.5	·	0.2	·	·	·	·	·	·	·	·	·	·	·	·
LT Debt / Equity	0.5	0.5	·	0.2	·	·	·	·	·	·	·	·	·	·	·	·
Interest Coverage	·	·	·	·	·	·	·	·	·	5.8	·	1.4	-0.1	-0.1	·	-1.7

Efficienza 3

Dati trimestrali Efficienza per ADMA
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.2	0.2	·	0.3	0.3	0.3	·	0.3	0.3	0.2	·	0.2	0.2	0.2	·	0.2
Inventory Turnover	0.2	0.2	·	0.3	0.3	0.3	·	0.4	0.3	0.3	·	0.3	0.3	0.3	·	0.2
Receivables Turnover	1.0	1.0	·	1.4	1.7	1.5	·	2.9	3.2	2.2	·	2.6	2.2	2.2	·	2.0

Per Azione 5

Dati trimestrali Per Azione per ADMA
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$1.81	$1.68	·	$1.81	$1.67	$1.57	·	$0.98	$0.81	$0.66	·	$0.67	$0.65	$0.66	·	$0.51
Revenue / Share	$0.54	$0.48	·	$0.55	$0.49	$0.47	·	$0.49	$0.44	$0.35	·	$0.29	$0.27	$0.26	·	$0.21
Cash Flow / Share	·	$0.24	·	·	·	$-0.08	·	·	·	$-0.01	·	·	·	$-0.07	·	·
Cash / Share	$0.60	$0.59	·	$0.26	$0.38	$0.30	·	$0.37	$0.38	$0.20	·	$0.33	$0.28	$0.31	·	$0.18
EPS (TTM)	$0.64	$0.59	·	$0.55	$0.53	$0.47	·	$0.37	$0.19	$0.03	·	$-0.13	$-0.21	$-0.31	·	$-0.41

Valutazione (TTM) 14

Dati trimestrali Valutazione (TTM) per ADMA
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$495M	$486M	·	$491M	$464M	$424M	·	$376M	$316M	$266M	·	$225M	$192M	$161M	·	$125M
Net Income TTM	$154M	$143M	·	$133M	$129M	$113M	·	$88M	$46M	$7M	·	$-25M	$-42M	$-60M	·	$-71M
Market Cap	$1.89B	$2.09B	·	$3.49B	$4.34B	$4.73B	·	$4.73B	$2.61B	$1.53B	·	$809M	$829M	$736M	·	$478M
Enterprise Value	$1.95B	$2.15B	·	$3.50B	·	·	·	·	·	·	·	·	·	·	·	·
P/E	13.1	15.3	·	26.7	34.4	42.2	·	54.0	58.8	220.0	·	-27.5	-17.6	-10.7	·	-5.9
P/S	3.8	4.3	·	7.1	9.4	11.2	·	12.6	8.2	5.7	·	3.6	4.3	4.6	·	3.8
P/B	4.6	5.4	·	8.1	10.9	12.7	·	20.4	13.8	10.0	·	5.3	5.6	5.1	·	4.8
P / Tangible Book	4.7	5.4	·	8.2	11.0	12.8	·	20.7	14.1	10.2	·	5.5	5.8	5.2	·	5.0
P / Cash Flow	·	35.9	·	·	·	-240.5	·	·	·	-689.7	·	·	·	-50.0	·	·
P / FCF	·	37.6	·	·	·	-194.1	·	·	·	-335.1	·	·	·	-44.1	·	·
EV / EBITDA	36.0	35.8	·	66.1	·	·	·	·	·	·	·	·	·	·	·	·
EV / FCF	·	38.6	·	·	·	·	·	·	·	·	·	·	·	·	·	·
EV / Revenue	3.9	4.4	·	7.1	·	·	·	·	·	·	·	·	·	·	·	·
Earnings Yield	7.6%	6.6%	·	3.8%	2.9%	2.4%	·	1.8%	1.7%	0.45%	·	-3.6%	-5.7%	-9.4%	·	-16.9%

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico

	2025-12-31	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Ricavi	$510M	—	—	$426M	—
Margine Lordo %	57.4%	—	—	51.5%	—
Margine Operativo %	37.5%	—	—	32.6%	—
Utile netto	$147M	—	—	$198M	—
EPS Diluito	$0.60	—	—	$0.81	—

Stato Patrimoniale

	2025-12-31	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Debito / Patrimonio Netto	0.2	—	—	—	—
Rapporto corrente	6.7	—	—	6.0	—
Quick Ratio	3.5	—	—	2.8	—

Flusso di cassa

	2025-12-31	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Flusso di cassa libero	$28M	—	—	$110M	—

Ultime notizie Notizie recenti che menzionano questa società

ADMA Biologics (ADMA) Riceve un'Espansione di Etichetta dalla FDA per ASCENIV Yahoo Finance · 2 mesi, 2 settimane fa
Ecco cosa pensano gli analisti di ADMA Biologics (ADMA) Yahoo Finance · 3 mesi fa
Mizuho Riduce il PT su ADMA Biologics Inc. (ADMA) a $24 da $30 Yahoo Finance · 3 mesi, 4 settimane fa
ADMA Biologics (ADMA) Annuncia un Programma di Restituzione di Capitali da 200 Milioni di Dollari, Inclusa un'Accordo ASR da 125 Milioni di Dollari Yahoo Finance · 4 mesi, 3 settimane fa

Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 364 filer · $1.2B totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
59 (-10 vs trimestre precedente)	81 (+19 vs trimestre precedente)	95 (-39 vs trimestre precedente)	136 (+25 vs trimestre precedente)	+18.6M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
STATE STREET CORP	$143.261.104	17.116.022	11,67%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$84.568.881	10.103.809	6,89%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$84.440.661	10.088.490	6,88%	Azioni
Rubric Capital Management LP	$78.170.895	9.339.414	6,37%	Azioni
Capital Research Global Investors	$73.290.850	8.756.374	5,97%	Azioni
FIRST TRUST ADVISORS LP	$65.272.197	7.798.351	5,32%	Azioni
Caligan Partners LP	$47.918.309	5.725.007	3,90%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$43.542.717	5.201.126	3,55%	Azioni
DIMENSIONAL FUND ADVISORS LP	$28.505.265	3.405.647	2,32%	Azioni
B Group, Inc.	$27.307.477	3.262.542	2,22%	Azioni
Nuveen Asset Management, LLC	$22.724.385	1.325.037	1,85%	Azioni
GOLDMAN SACHS GROUP INC	$21.445.388	2.562.173	1,75%	Azioni
Nantahala Capital Management, LLC	$19.753.141	2.359.993	1,61%	Azioni
D. E. Shaw & Co., Inc.	$19.393.708	2.317.050	1,58%	Azioni
Ranger Investment Management, L.P.	$17.706.040	2.115.417	1,44%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$17.515.012	2.092.594	1,43%	Azioni
TWO SIGMA INVESTMENTS, LP	$16.906.454	2.019.887	1,38%	Azioni
KENNEDY CAPITAL MANAGEMENT LLC	$14.690.622	1.755.152	1,20%	Azioni
VANGUARD FIDUCIARY TRUST CO	$13.849.111	1.654.613	1,13%	Azioni
Fundsmith LLP	$13.806.256	1.649.493	1,12%	Azioni
Mesirow Institutional Investment Management, Inc.	$13.419.035	782.451	1,09%	Azioni
Life Cycle Investment Partners Ltd	$12.747.351	1.522.981	1,04%	Azioni
BANK OF AMERICA CORP /DE/	$12.489.672	1.492.195	1,02%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$12.172.449	1.454.295	0,99%	Azioni
CITADEL ADVISORS LLC	$11.467.494	1.370.071	0,93%	Azioni
PRINCIPAL FINANCIAL GROUP INC	$11.400.467	1.362.063	0,93%	Azioni
Clearline Capital LP	$11.171.648	1.334.725	0,91%	Azioni
Qube Research & Technologies Ltd	$11.019.674	1.316.568	0,90%	Azioni
National Philanthropic Trust	$10.006.302	1.195.496	0,82%	Azioni
BOOTHBAY FUND MANAGEMENT, LLC	$9.848.828	1.176.682	0,80%	Azioni
MILLENNIUM MANAGEMENT LLC	$9.660.888	1.154.228	0,79%	Azioni
Caption Management, LLC	$8.370.000	1.000.000	0,68%	Opzione Put
Stonepine Capital Management, LLC	$7.950.000	650.000	0,65%	Opzione Call
Public Sector Pension Investment Board	$6.664.370	796.221	0,54%	Azioni
ALGERT GLOBAL LLC	$6.505.072	777.189	0,53%	Azioni
Stonepine Capital Management, LLC	$6.193.800	740.000	0,50%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$5.749.537	686.922	0,47%	Azioni
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	$5.582.790	667.000	0,45%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$5.461.676	652.530	0,44%	Azioni
ARDSLEY ADVISORY PARTNERS LP	$5.022.000	600.000	0,41%	Azioni
Y-Intercept (Hong Kong) Ltd	$4.800.873	573.581	0,39%	Azioni
JUPITER ASSET MANAGEMENT LTD	$4.755.282	568.134	0,39%	Azioni
Caption Management, LLC	$4.603.500	550.000	0,37%	Opzione Call
RHUMBLINE ADVISERS	$4.485.141	535.862	0,37%	Azioni
MORGAN STANLEY	$4.475.046	534.653	0,36%	Azioni
MARATHON CAPITAL MANAGEMENT	$4.455.795	532.353	0,36%	Azioni
JANE STREET GROUP, LLC	$4.363.582	521.336	0,36%	Azioni
Caption Management, LLC	$3.933.900	470.000	0,32%	Azioni
CITIGROUP INC	$3.932.084	469.783	0,32%	Azioni
Swiss National Bank	$3.707.073	442.900	0,30%	Azioni
Ruffer LLP	$3.536.005	422.958	0,29%	Azioni
AMERIPRISE FINANCIAL INC	$3.495.939	417.675	0,28%	Azioni
Point72 Asset Management, L.P.	$3.464.636	413.935	0,28%	Azioni
Bridgewater Associates, LP	$3.356.864	401.059	0,27%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$3.303.639	394.700	0,27%	Opzione Call
ASHFORD CAPITAL MANAGEMENT INC	$3.257.115	361.500	0,27%	Azioni
FMR LLC	$3.249.586	388.242	0,26%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$3.101.085	370.500	0,25%	Opzione Put
Squarepoint Ops LLC	$2.992.300	357.503	0,24%	Azioni
Legal & General Group Plc	$2.970.780	354.932	0,24%	Azioni
Quantinno Capital Management LP	$2.767.800	330.681	0,23%	Azioni
BlackRock, Inc.	$2.716.216	324.518	0,22%	Azioni
ALLIANCEBERNSTEIN L.P.	$2.683.926	297.883	0,22%	Azioni
Corient Private Wealth LP	$2.667.295	318.673	0,22%	Azioni
MARSHALL WACE, LLP	$2.571.717	307.254	0,21%	Azioni
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	$2.514.907	279.124	0,20%	Azioni
Caligan Partners LP	$2.511.000	300.000	0,20%	Opzione Call
STATE OF WISCONSIN INVESTMENT BOARD	$2.370.417	283.204	0,19%	Azioni
PFG Investments, LLC	$2.261.390	270.178	0,18%	Azioni
Velan Capital Investment Management LP	$2.092.500	250.000	0,17%	Azioni
Future Fund LLC	$2.080.146	248.524	0,17%	Azioni
H D Vest Advisory Services	$2.024.515	111.176	0,16%	Azioni
PRUDENTIAL FINANCIAL INC	$2.007.168	239.805	0,16%	Azioni
AMERICAN CENTURY COMPANIES INC	$1.895.961	226.518	0,15%	Azioni
Campbell & CO Investment Adviser LLC	$1.875.215	224.040	0,15%	Azioni
WOLVERINE TRADING, LLC	$1.821.330	123.900	0,15%	Opzione Call
Rafferty Asset Management, LLC	$1.807.887	215.996	0,15%	Azioni
VANGUARD ASSET MANAGEMENT, Ltd	$1.724.379	206.019	0,14%	Azioni
DIADEMA PARTNERS LP	$1.674.000	200.000	0,14%	Opzione Call
Mariner, LLC	$1.496.157	178.752	0,12%	Azioni
VIRGINIA RETIREMENT SYSTEMS ET Al	$1.357.731	74.437	0,11%	Azioni
LPL Financial LLC	$1.336.311	159.655	0,11%	Azioni
INTECH INVESTMENT MANAGEMENT LLC	$1.260.355	150.580	0,10%	Azioni
WOLVERINE TRADING, LLC	$1.211.280	82.400	0,10%	Opzione Put
Virtus Investment Advisers, LLC	$1.185.544	141.642	0,10%	Azioni
XTX Topco Ltd	$1.182.756	141.309	0,10%	Azioni
UBS Group AG	$1.127.774	134.740	0,09%	Azioni
MetLife Investment Management, LLC	$1.125.732	134.496	0,09%	Azioni
RAYMOND JAMES FINANCIAL INC	$1.098.563	131.250	0,09%	Azioni
Nuveen, LLC	$1.078.901	128.901	0,09%	Azioni
Cetera Investment Advisers	$1.073.310	128.233	0,09%	Azioni
VANGUARD GROUP INC	$1.065.526	58.417	0,09%	Azioni
CreativeOne Wealth, LLC	$1.062.371	126.926	0,09%	Azioni
CITADEL ADVISORS LLC	$1.057.131	126.300	0,09%	Opzione Call
Odyssean, LLC	$1.042.048	124.498	0,08%	Azioni
MANUFACTURERS LIFE INSURANCE COMPANY, THE	$1.041.086	124.383	0,08%	Azioni
CITADEL ADVISORS LLC	$1.037.043	123.900	0,08%	Opzione Put
Illinois Municipal Retirement Fund	$988.991	118.159	0,08%	Azioni
PROFUND ADVISORS LLC	$988.581	118.110	0,08%	Azioni
PERCEPTIVE ADVISORS LLC	$952.213	113.765	0,08%	Azioni

Insider aziendali 20 insider · 8 dirigenti · 12 direttori

Insider	Ruolo	Ultima attività	Azioni possedute	Acquisti 12m	Vendite 12m	Netto 12m
Adam S Grossman	President and CEO	16 Marzo 2026 M	2.112.777	0	12	$-2.082.360
Terry Kohler	CFO and Treasurer	16 Luglio 2026 A	143.149	0	0	$0
Brad L. Tade	CFO and Treasurer	19 Febbraio 2026 F	232.940	0	0	$0
Brian Lenz	EVP, CFO	07 Marzo 2024 F	703.002	0	0	$0
Kirk M Warshaw	CFO, Secretary	13 Febbraio 2012 D	5.208	0	0	$0
Arnold P Kling	President	13 Febbraio 2012 D	8.485	0	0	$0
Kaitlin M. Kestenberg-Messina	COO and SVP, Compliance	24 Luglio 2026 F	443.061	0	1	$-157.800
James Mond	EVP, CSO and CMO	25 Febbraio 2021 A	137.535	0	0	$0
Jerrold B Grossman	Direttore	27 Maggio 2026 P	520.284	3	0	$250.874
Lawrence P. Guiheen	Direttore	13 Marzo 2026 M	30.000	0	0	$0
Steve Elms	Direttore	06 Marzo 2026 P	2.045.730	2	0	$217.420
Eduardo Rene Salas	Direttore	09 Febbraio 2026 A	21.579	0	0	$0
Young Kwon	Direttore	09 Febbraio 2026 A	263.020	0	0	$0
Alison Cecily Finger	Direttore	09 Febbraio 2026 A	45.619	0	0	$0
Bryant Fong	Direttore	26 Febbraio 2024 A	83.941	0	0	$0
Martha J Demski	Direttore	06 Marzo 2023 A	56.601	0	0	$0
Eric I Richman	Direttore	28 Febbraio 2020 A	44.030	0	0	$0
GOLDSTEIN DOV A MD	Direttore	28 Febbraio 2020 A	7.500	0	0	$0
Biotest Divestiture Trust	Proprietario del 10%	06 Giugno 2019 S	4.295.580	0	0	$0
R & R INVESTMENTS VI LLC	Proprietario del 10%	13 Febbraio 2012 D	39.340	0	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Attivisti e proprietari del 5%+ 9 partecipazioni

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
Caligan Partners LP, David Johnson ×2 depositi	09 Dicembre 2022	—	Deposito iniziale	Investimento passivo	SEC
The Biotest Divestiture Trust, Eric Rosenbach ×2 depositi	07 Giugno 2019	—	Deposito iniziale	—	SEC
Biotest AG ×3 depositi	03 Agosto 2018	—	Deposito iniziale	—	SEC
Biotest Pharmaceuticals Corporation	21 Maggio 2018	—	Deposito iniziale	—	SEC
OR ×8 depositi	16 Novembre 2017	—	Deposito iniziale	—	SEC
Biomark Capital Fund IV LP (the “Fund”), Biomark Capital Fund IV GP LLC (the “General Partner”), David S. Wetherell (“Wetherell”)	30 Gennaio 2017	—	Deposito iniziale	—	SEC
Burrill Capital Fund IV, L.P. (the “Fund”), Burrill & Company (BCF IV GP), LLC (the “General Partner”), G. Steven Burrill (“Burrill”), Bryant Fong (“Fong”), Victor Hebert (“Hebert”), Douglas Lind (“Lind”), David Wetherell (“Wetherell”), Joshua Zelig (“Zelig”) ×2 depositi	28 Ottobre 2013	—	Deposito iniziale	—	SEC
Persona segnalante non divulgata	15 Settembre 2006	—	Deposito iniziale	—	SEC
Persona segnalante non divulgata	08 Settembre 2006	—	Deposito iniziale	—	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Proprietà ETF Posseduti da 63 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
TMFS · RBB Fund, Inc.	1,30%	96.557 NS	31 Maggio 2026	N-PORT
PSCH · Invesco Exchange-Traded Fund Trust …	1,16%	201.155 SH	08 Agosto 2026	Giornaliero
BBP · ETFis Series Trust I	0,83%	47.844 NS	30 Aprile 2026	N-PORT
LABU · Direxion Shares ETF Trust	0,56%	281.674 NS	30 Aprile 2026	N-PORT
FSCC · Federated Hermes ETF Trust	0,32%	109.641 NS	31 Maggio 2026	N-PORT
RZG · Invesco Exchange-Traded Fund Trust	0,28%	38.671 SH	08 Agosto 2026	Giornaliero
IJT · iShares Trust	0,26%	2.149.439 SH	08 Agosto 2026	Giornaliero
VIOG · VANGUARD ADMIRAL FUNDS	0,21%	275.878 SH	08 Agosto 2026	Giornaliero
IBB · iShares Trust	0,17%	1.652.272 SH	08 Agosto 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,16%	12.612 SH	08 Agosto 2026	Giornaliero
XJR · iShares Trust	0,15%	27.488 SH	08 Agosto 2026	Giornaliero
IWO · iShares Trust	0,14%	2.077.912 SH	08 Agosto 2026	Giornaliero
QVMS · Invesco Exchange-Traded Fund Trust …	0,14%	35.750 SH	08 Agosto 2026	Giornaliero
IJR · iShares Trust	0,13%	14.148.426 SH	08 Agosto 2026	Giornaliero
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0,13%	90.151 NS	30 Aprile 2026	N-PORT
BFOR · ALPS ETF Trust	0,12%	32.818 NS	31 Maggio 2026	N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS	0,11%	247.366 SH	08 Agosto 2026	Giornaliero
BKSE · BNY Mellon ETF Trust	0,10%	8.106 NS	30 Aprile 2026	N-PORT
VIOO · VANGUARD ADMIRAL FUNDS	0,10%	807.920 SH	08 Agosto 2026	Giornaliero
BIB · ProShares Trust	0,10%	8.805 NS	31 Maggio 2026	N-PORT
SAA · ProShares Trust	0,08%	2.846 NS	31 Maggio 2026	N-PORT
IWM · iShares Trust	0,07%	5.870.129 SH	08 Agosto 2026	Giornaliero
ISCG · iShares Trust	0,07%	70.846 SH	08 Agosto 2026	Giornaliero
SMDX · Tidal Trust III	0,07%	8.104 NS	30 Aprile 2026	N-PORT
GSSC · Goldman Sachs ETF Trust	0,07%	81.574 NS	31 Maggio 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,06%	1.327.333 SH	08 Agosto 2026	Giornaliero
DFAS · Dimensional ETF Trust	0,06%	791.152 NS	30 Aprile 2026	N-PORT
JPSE · J.P. Morgan Exchange-Traded Fund Tr…	0,05%	31.008 NS	30 Aprile 2026	N-PORT
ITWO · ProShares Trust	0,05%	10.910 NS	31 Maggio 2026	N-PORT
AVSC · AMERICAN CENTURY ETF TRUST	0,04%	150.270 NS	31 Maggio 2026	N-PORT
EBIT · Harbor ETF Trust	0,04%	449 NS	30 Aprile 2026	N-PORT
SCHA · SCHWAB STRATEGIC TRUST	0,04%	1.140.912 NS	31 Maggio 2026	N-PORT
FHLC · FIDELITY COVINGTON TRUST	0,04%	109.138 NS	30 Aprile 2026	N-PORT
RWJ · Invesco Exchange-Traded Fund Trust …	0,04%	77.725 SH	08 Agosto 2026	Giornaliero
ISCB · iShares Trust	0,04%	10.075 SH	08 Agosto 2026	Giornaliero
VBK · VANGUARD INDEX FUNDS	0,03%	1.448.225 SH	08 Agosto 2026	Giornaliero
VHT · VANGUARD WORLD FUND	0,03%	664.197 SH	08 Agosto 2026	Giornaliero
UWM · ProShares Trust	0,03%	8.533 NS	31 Maggio 2026	N-PORT
WSML · iShares Trust	0,02%	14.368 SH	08 Agosto 2026	Giornaliero
VXF · VANGUARD INDEX FUNDS	0,02%	2.659.600 SH	08 Agosto 2026	Giornaliero
URTY · ProShares Trust	0,02%	8.634 NS	31 Maggio 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,01%	31.610 SH	08 Agosto 2026	Giornaliero
VB · VANGUARD INDEX FUNDS	0,01%	2.517.984 SH	08 Agosto 2026	Giornaliero
AVIE · AMERICAN CENTURY ETF TRUST	0,01%	128 NS	31 Maggio 2026	N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS	0,01%	9.059 NS	31 Maggio 2026	N-PORT
HDG · ProShares Trust	0,01%	217 NS	31 Maggio 2026	N-PORT
ONEQ · Fidelity Commonwealth Trust	0,00%	63.237 NS	31 Maggio 2026	N-PORT
TILT · FlexShares Trust	0,00%	7.854 NS	30 Aprile 2026	N-PORT
DFAC · Dimensional ETF Trust	0,00%	151.191 NS	30 Aprile 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	37.593 NS	30 Aprile 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	66.532 NS	30 Aprile 2026	N-PORT
IWV · iShares Trust	0,00%	65.716 SH	08 Agosto 2026	Giornaliero
ITOT · iShares Trust	0,00%	309.568 SH	08 Agosto 2026	Giornaliero
DXUV · Dimensional ETF Trust	0,00%	1.043 NS	30 Aprile 2026	N-PORT
SCHB · SCHWAB STRATEGIC TRUST	0,00%	139.699 NS	31 Maggio 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	5.446 NS	30 Aprile 2026	N-PORT
AVUQ · AMERICAN CENTURY ETF TRUST	0,00%	411 NS	31 Maggio 2026	N-PORT
SMIZ · Zacks Trust	0,00%	395 NS	31 Maggio 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	7.025.272 SH	08 Agosto 2026	Giornaliero
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0,00%	192.148 SH	08 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	19.272 SH	08 Agosto 2026	Giornaliero
EBI · RBB Fund Trust	0,00%	40 NS	31 Maggio 2026	N-PORT
ESGV · VANGUARD WORLD FUND	0,00%	50.502 SH	08 Agosto 2026	Giornaliero

Informazioni su ADMA Biologics Inc - Common Stock Panoramica della società da Wikipedia

ADMA Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

ADMA Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Medie mobili e sovrapposizioni

Volume

Oscillatori

Momentum e tendenza

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

ADMA Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Ultime notizie Notizie recenti che menzionano questa società

Segnali di trading Segnali recenti di acquisto/vendita con prezzo di entrata e rapporto rischio/rendimento

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

Proprietari istituzionali (13F) 364 filer · $1.2B totale · Aggiornato al 30 Giugno 2026

Insider aziendali 20 insider · 8 dirigenti · 12 direttori

Attivisti e proprietari del 5%+ 9 partecipazioni

Proprietà ETF Posseduti da 63 ETF